ID Biomedical Gets U.S. Flu Drug Deal (Reuters) Reuters - ID Biomedical Corp.  \signed a 10-year U.S. distribution deal for its Fluviral drug\that could reap sales of  #36;2.3 billion and help U.S. authorities\fill a flu vaccine shortage, the company said on Monday.